McKinsey & Company to pay $650 million to settle U.S. opioid consulting probe A former top partner at McKinsey has also agreed to plead guilty to obstruction of justice in the federal probe ...

McKinsey & Co. has agreed to pay $650 million to resolve a Justice Department investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how to ...

McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe into the company’s consulting work advising Purdue Pharma on how to ...

A former top partner at McKinsey, Martin Elling, also agreed to plead guilty to obstruction of justice next month in the probe by the U.S. Department of Justice, according to a filing in U.S ...

McKinsey to settle opioid work probe. Consulting firm agrees to pay $650M. December 14, 2024 at 1:46 a.m. by GEOFF MULVIHILL and ALANNA DURKIN RICHER The Associated Press ...

In 2019, McKinsey announced it would no longer advise clients on opioid-related businesses. The company has maintained that none of the settlements contain admissions of liability or wrongdoing ...

Lawmakers are calling for a probe into McKinsey & Company after the consulting giant allegedly skirted conflict-of-interest rules in its work on opioid-related issues.

McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe into the company's consulting work ...